Healthcare companies are lining up to go public, and they could get a warmer reception in 2010 as investors' risk appetite increases, and new legislation potentially leads to more profit for the sector. The US Senate on Thursday approved President Barack Obama's healthcare reform bill. It must negotiate with the House of Representatives over a final version, but if the bill passes, it wou… Read all
Outlook for healthcare IPOs improving for 2010
|
ReNeuron trials - Injecting Cells Into Brains Means Test for Investors
In Scotland a patient will be the first of 12 men disabled by strokes plans to have hole drilled in the patient’s skull, a needle inserted and injection of 2 million stem cells from ReNeuron into his brain early next year. The studiy will last for two years to see if the cells help the brain repair damage, without causing further harm. ReNeuron won U.K. government approval… Read all |
Osiris Therapeutics stem cell products used for heart dsiease move through trials
Researchers are using a mesenchymal stem cell therapy that is marketed by Osiris Therapeutics under the name Prochymal. The stem cells reduce the amount of scar tissue and increase the pumping strength of the heart in heart attack patients, and to a limited extent, they also… Read all |
Sanofi Recalls 800,000 Swine Flu Shots based on low Potency
Sanofi-Aventis SA recalled 800,000 doses of swine flu vaccine after testing showed the potency of the batches was too low, the said U.S. Centers for Disease Control and Prevention. The shots are safe, and people who have already been inoculated don’t need to get vaccinated again, said Anne Schuchat, head of the CDC’s National Center for Immunization and Respiratory Diseases. Doctor… Read all |
Swine flu infections in the USA, Norway and UK have mutated to a form that’s more severe or less sensitive to drug treatment
In the USA, Norway and UK swine flu infections in which the virus has mutated to a form that’s more severe or less sensitive to drug treatment are being investigated by European and U.S. public health officials. Five patients at a hospital in Wales contracted swine flu that resisted treatment with Roche Holding AG’s Tamiflu, and three more infections are being analyzed, the U.K. Health Prot… Read all |